https://www.selleckchem.com/products/amg-232.html
Chromogranin A (CgA) is the most widely accepted biomarker for neuroendocrine tumors (NET) but its diagnostic accuracy is dependent on tumor type and the use of proton-pump inhibitors (PPI). We investigated the diagnostic value of circulating miRNAs along with CgA in pancreatic neuroendocrine tumors (pNET). 74 serum samples from patients with pNET (n = 25, nonfunctioning), pheochromocytoma/paraganglioma (PPGL, n = 2, healthy individuals with normal CgA (n = 29) including 10 samples from 5 healthy individuals with and without current P
Aimer
Commentaire
Partagez
